G'day @benportaMate Thanks for your Kind words I really...

First 22 Last

Share
Profile

Follow
big finn

722 Posts.

186

07/03/19

19:53

Post #: 37690549
Share

Originally posted by benporta: ↑

Hi big fin. I just like to thank you and others for your contributions on these topics of how this company works! You and others have caused me to go and enlighten myself to go and review the company’s annual reports and pay close attention to how and what services are provided and how they are paid for. I have gone back to 2014 annual report to the latest 2018.
constant theme is “share based payment arrangements” (it can be very lucrative for those who are paid this way I would assume) for
-convertible notes ( who is providing those?)
-share payments for consulting services ( who is the consulting person or companies providing this service)
-share payments to AGMPL employees
-the main holders of companies and entities
on top of the list of services provided by AGMPL as listed in Note 33 of 2018 report.
And I wonder what this Dr Robert Coeraads does for this $360,000 year on year. (Writes lots of books) I hope this stops (doubt it)now that our focus is on the hemp and mm.
IMO this has been a gold mine without doing any digging.
However for now I do believe in the new enitity CANN GLOBAL Limited and really hope it thrives, as I have a considerable amount invested, but I do hope they don’t continue this share based payment arrangements.
Any way thanks big Finn and all other contributors whether they have skin in the game or not, you all keep us informed whether we like it or not

-

Expand

G'day @benporta

Mate Thanks for your Kind words I really appreciate them.

I will continue researching QBL/CGB along with any deals they make whilst I'm waiting for them to relist, on that point Canntab have released many interviews on Stocktube and Youtube outlining their plans for the future that are worth spending the time watching,
some of the points to be picked out of some of the interviews with Jeff Renwick, Canntabs CEO and Richard Goldstein CFO are Canntabs plans to Manufacture their Canntab XR tablets in Canada and Distribute them throughout the world, with no talk of partnerships to produce these Tablets anywhere but in Canada..
Also Canntabs Financial and annual reports are a real eye opener particularly in because CGB are saying they are working in a JV with them.

Cheers
Finn

CGB Price at posting: 3.7¢ Sentiment: Sell Disclosure: Held
3 Upvote

2 Great analysis

Reply

Top Stories

Trump is President Again: What Does This Mean for Crypto?

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

ACW

Actinogen receives $9M R&D tax rebate to fund Alzheimer's trial

NHF

Burgeoning NZ insurance claims drive 1H25 operating loss for nib

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels